Skip to search formSkip to main contentSkip to account menu

Sustiva

Known as: Bristol-Myers Squibb brand of efavirenz, Du Pont brand of efavirenz, United Drug brand of efavirenz 
National Institutes of Health

Related topics

Related topics

4 relations
Stocrinefavirenz 200 MG Oral Capsule [Sustiva]efavirenz 600 MG Oral Tablet [Sustiva]

Broader (1)

efavirenz

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.
Review
2000
Review
2000
Efavirenz (Sustiva).
Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), was an important part of initial combination antiretroviral… 
1999
1999
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors.
Efavirenz (SUSTIVA) is a potent non-nucleoside reverse transcriptase inhibitor. Due to the observation of breakthrough mutations… 
1999
1999
Sustiva may cause false positive on marijuana test.
Sustiva may cause false positives on urine tests that screen for marijuana use. A false positive, however, is unlikely to… 
1999
1999
Sustiva flashbacks.
The PWA Health Group of New York City reports that some users of the anti-HIV drug Sustiva (efavirenz) who are recovering from… 
1998
1998
Sustiva (efavirenz) is approved.
A non-nucleoside reverse transcriptase inhibitor, Sustiva (efavirenz, formerly DMP 266), received FDA approval for use by… 
1998
1998
Sustiva yields false positives on marijuana tests.
Dupont Pharma officials have confirmed that Sustiva (efavirenz) has been shown to cause false positives on THC tests. THC tests… 
1998
1998
Safety alert issued on efavirenz (Sustiva).
Studies of efavirenz (Sustiva, formerly DMP-266) in monkeys have shown newborn monkeys with abnormalities. Dupont Merck, the… 
1998
1998
Efavirenz (Sustiva) on fast-track for FDA accelerated approval. Food and Drug Administration.
The Food and Drug Administration (FDA) is considering expediting the approval process of efavirenz, a NNRTI drug. If efavirenz… 
1997
1997
Efavirenz (SUSTIVA) expanded access begins October 1.
: Efavirenz (SUSTIVA, formerly DMP 266), is being made available to AIDS patients who are failing or are intolerant of their… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)